Vicus Therapeutics, Inc., an oncology-focused, clinical-stage biopharmaceutical company, announced recently that Chief Executive Officer, John Maki, and Chief Scientific Officer, Frederic Young, Ph.D., will each present at the 234th American Chemical Society National Meeting on Sunday, August 19, 2007
More...
More...